| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 10 |
| 1 | FLUOROURACIL CREAM, 0.5% | 10 |
| 2 | OXALIPLATIN | 9 |
| 3 | SACITUZUMAB GOVITECAN | 3 |
| 4 | ALPRAZOLAM | 1 |
| 5 | IRINOTECAN HYDROCHLORIDE | 1 |
| 6 | SODIUM CHLORIDE | 1 |
| 7 | SODIUM CHLORIDE TABLET | 1 |
| 8 | SODIUM CHLORIDE TABLETS | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SACITUZUMAB GOVITECAN | 3 | 0.0006 |
| 1 | FLUOROURACIL CREAM, 0.5% | 10 | 0.0001 |
| 2 | FLUOROURACIL | 10 | 0.0001 |
| 3 | OXALIPLATIN | 9 | 0.0001 |
| 4 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| 5 | SODIUM CHLORIDE TABLET | 1 | 0.0000 |
| 6 | SODIUM CHLORIDE TABLETS | 1 | 0.0000 |
| 7 | SODIUM CHLORIDE | 1 | 0.0000 |
| 8 | ALPRAZOLAM | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 1 | Platinum-based Drug [EPC] | 9 |
| 2 | Benzodiazepine [EPC] | 1 |
| 3 | Osmotic Laxative [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 1 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 2 | Osmotic Laxative [EPC] | 1 | 0.0000 |
| 3 | Benzodiazepine [EPC] | 1 | 0.0000 |